Originally published September 9, 2019 by Kristina Naseman, PharmD, MPH, MLDE, BCACP, CDE
The Biologics Price Competition and Innovation Act created the opportunity for biosimilar products to enter the drug market in the U.S. The future impact on the insulin market and diabetes care is still to be determined.
Originally published March 11, 2019 by David Spero, BSN, RN
What keeps your patients from managing their diabetes? One common cause is depression. Screening and treating patients for depression can often start them feeling better and improving their glucose control.